The aMAP score improves discrimination of prognostic models in hepatocellular carcinoma after radiofrequency ablation

1

The aMAP score is a reliable model for predicting hepatocellular carcinoma (HCC) recurrence after radiofrequency ablation (RFA).
2

In a study of 350 HCC patients post-RFA, those with low aMAP scores showed significantly longer recurrence-free survival (RFS).
3

Multivariate analysis confirmed the aMAP score as an independent prognostic factor for RFS in HCC patients after RFA treatment.
4

Incorporating the aMAP score into existing models improved predictive accuracy for HCC recurrence, as indicated by IDI and NRI metrics.
5

This study expands the clinical application of the aMAP score, providing a novel reference for assessing post-RFA recurrence risk in HCC patients.

Frontiers In Oncology

by Luchang Fan, Yiyan Zhang, Jianmin Ding, Yan Zhou, Jun Li, Qiong Wu, Shuqin Cheng, Fengmei Wang, Xiang Jing
June 17, 2026

1